Unknown

Dataset Information

0

The Bruton tyrosine kinase inhibitor zanubrutinib (BGB-3111) demonstrated synergies with other anti-lymphoma targeted agents.


ABSTRACT:

SUBMITTER: Tarantelli C 

PROVIDER: S-EPMC6601092 | biostudies-literature | 2019 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

The Bruton tyrosine kinase inhibitor zanubrutinib (BGB-3111) demonstrated synergies with other anti-lymphoma targeted agents.

Tarantelli Chiara C   Zhang Lu L   Curti Elisabetta E   Gaudio Eugenio E   Spriano Filippo F   Priebe Valdemar V   Cascione Luciano L   Arribas Alberto J AJ   Zucca Emanuele E   Rossi Davide D   Stathis Anastasios A   Bertoni Francesco F  

Haematologica 20190124 7


Similar Datasets

| S-EPMC9401548 | biostudies-literature
| S-EPMC7556127 | biostudies-literature
| S-EPMC6363842 | biostudies-literature
| S-EPMC7936706 | biostudies-literature
| S-EPMC8457562 | biostudies-literature
| S-EPMC10461952 | biostudies-literature
| S-EPMC5581705 | biostudies-literature
| S-EPMC5399483 | biostudies-literature
| S-EPMC8318668 | biostudies-literature